Identification and functional characterization of novel phosphorylation sites in TAK1-binding protein (TAB) 1

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Wolf, Alexander ^a   Beuerlein, Knut ^a   Eckart, Christoph ^a   Weiser, Hendrik ^a   Dickkopf, Beate ^a   Müller, Helmut ^a   Sakurai, Hiroaki ^b   Kracht, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANISOMYCIN; CALYCULIN A; CYTOKINE; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; PHOSPHATASE; PROTEIN TAB1; RANTES; SERINE; SORBITOL; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; PRIMER DNA; SIGNAL PEPTIDE; TAB1 PROTEIN, MAPKKK ACTIVATOR, VERTEBRATE;

3' UNTRANSLATED REGION; AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; EMBRYO; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PHYSIOLOGICAL STRESS; RNA PROCESSING; SEQUENCE HOMOLOGY; UBIQUITINATION; VALIDATION STUDY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; CYTOKINES; CYTOPLASM; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEQUENCE HOMOLOGY, AMINO ACID; STRESS, PHYSIOLOGICAL; UBIQUITINATION;

EID: 84055207523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029256     Document Type: Article

References (54)

1. Gaestel M, Kotlyarov A, Kracht M, (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov 8: 480-499.
2. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA, (2006) The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 7: 851-858.
3. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095.
4. Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, et al. (2002) Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol 22: 992-1000.
5. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, et al. (1999) The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256.
6. Singhirunnusorn P, Suzuki S, Kawasaki N, Saiki I, Sakurai H, (2005) Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem 280: 7359-7368.
7. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, et al. (1996) TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272: 1179-1182.
8. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, et al. (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5: 649-658.
9. Jin G, Klika A, Callahan M, Faga B, Danzig J, et al. (2004) Identification of a human NF-kappaB-activating protein, TAB3. Proc Natl Acad Sci U S A 101: 2028-2033.
10. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, et al. (2003) Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 22: 6277-6288.
11. Holtmann H, Enninga J, Kalble S, Thiefes A, Dorrie A, et al. (2001) The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem 276: 3508-3516.
12. Cheung PC, Nebreda AR, Cohen P, (2004) TAB3, a new binding partner of the protein kinase TAK1. Biochem J 378: 27-34.
13. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, et al. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351.
14. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, et al. (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15: 535-548.
15. Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, et al. (2006) The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep 7: 838-844.
16. Sakurai H, Nishi A, Sato N, Mizukami J, Miyoshi H, et al. (2002) TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. Biochem Biophys Res Commun 297: 1277-1281.
17. Sakurai H, Miyoshi H, Mizukami J, Sugita T, (2000) Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett 474: 141-145.
18. Kishimoto K, Matsumoto K, Ninomiya-Tsuji J, (2000) TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 275: 7359-7364.
19. Ono K, Ohtomo T, Sato S, Sugamata Y, Suzuki M, et al. (2001) An evolutionarily conserved motif in the TAB1 C-terminal region is necessary for interaction with and activation of TAK1 MAPKKK. J Biol Chem 276: 24396-24400.
20. Cheung PC, Campbell DG, Nebreda AR, Cohen P, (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. EMBO J 22: 5793-5805.
21. Ge B, Xiong X, Jing Q, Mosley JL, Filose A, et al. (2003) TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem 278: 2286-2293.
22. Zhou H, Zheng M, Chen J, Xie C, Kolatkar AR, et al. (2006) Determinants that control the specific interactions between TAB1 and p38alpha. Mol Cell Biol 26: 3824-3834.
23. Kang YJ, Seit-Nebi A, Davis RJ, Han J, (2006) Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J Biol Chem 281: 26225-26234.
24. Ge B, Gram H, Di Padova F, Huang B, New L, et al. (2002) MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295: 1291-1294.
25. Conner SH, Kular G, Peggie M, Shepherd S, Schuttelkopf AW, et al. (2006) TAK1-binding protein 1 is a pseudophosphatase. Biochem J 399: 427-434.
26. Mendoza H, Campbell DG, Burness K, Hastie J, Ronkina N, et al. (2008) Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem J 409: 711-722.
27. Hanada M, Ninomiya-Tsuji J, Komaki K, Ohnishi M, Katsura K, et al. (2001) Regulation of the TAK1 signaling pathway by protein phosphatase 2C. J Biol Chem 276: 5753-5759.
28. Kajino T, Ren H, Iemura S, Natsume T, Stefansson B, et al. (2006) Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J Biol Chem 281: 39891-39896.
29. Liu Q, Busby JC, Molkentin JD, (2009) Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11: 154-161.
30. Kettner-Buhrow D, Dittrich-Breiholz O, Schneider H, Wolter S, Resch K, et al. (2006) Small interfering RNAs generated by recombinant dicer induce inflammatory gene expression independent from the TAK1-NFkappaB-MAPK signaling pathways. Biochem Biophys Res Commun 347: 566-573.
31. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K, et al. (2003) TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 326: 105-115.
32. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, et al. (2006) TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 281: 19610-19617.
33. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19: 2668-2681.
34. Inagaki M, Omori E, Kim JY, Komatsu Y, Scott G, et al. (2008) TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling. J Biol Chem 283: 33080-33086.
35. Li MG, Katsura K, Nomiyama H, Komaki K, Ninomiya-Tsuji J, et al. (2003) Regulation of the interleukin-1-induced signaling pathways by a novel member of the protein phosphatase 2C family (PP2Cepsilon). J Biol Chem 278: 12013-12021.
36. Baril C, Sahmi M, Ashton-Beaucage D, Stronach B, Therrien M, (2009) The PP2C Alphabet Is a Negative Regulator of Stress-Activated Protein Kinase Signaling in Drosophila. Genetics 181: 567-579.
37. Lu G, Kang YJ, Han J, Herschman HR, Stefani E, et al. (2006) TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J Biol Chem 281: 6087-6095.
38. Askari N, Beenstock J, Livnah O, Engelberg D, (2009) p38 is Active in vitro and in vivo when Monophosphorylated on Thr180. Biochemistry 48: 2497-2504.
39. Ben Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ, (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8: 1049-1057.
40. Bertelsen M, Sanfridson A, (2007) TAB1 modulates IL-1alpha mediated cytokine secretion but is dispensable for TAK1 activation. Cell Signal 19: 646-657.
41. Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR, (2002) Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am J Physiol Lung Cell Mol Physiol 283: L1280-L1290 10.1152/ajplung.00162.2002 [doi];00162.2002 [pii].
42. Prickett TD, Ninomiya-Tsuji J, Broglie P, Muratore TL, Shabanowitz J, et al. (2008) TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappa B. J Biol Chem.
43. Mendoza H, Campbell DG, Burness K, Hastie J, Ronkina N, et al. (2008) Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem J 409: 711-722.
44. Engel K, Kotlyarov A, Gaestel M, (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17: 3363-3371.
45. Lu M, Lin SC, Huang Y, Kang YJ, Rich R, et al. (2007) XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 26: 689-702.
46. Brown K, Vial SC, Dedi N, Long JM, Dunster NJ, et al. (2005) Structural basis for the interaction of TAK1 kinase with its activating protein TAB1. J Mol Biol 354: 1013-1020.
47. Dingwall C, Laskey RA, (1998) Nuclear import: a tale of two sites. Curr Biol 8: R922-R924.
48. Chuderland D, Konson A, Seger R, (2008) Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 31: 850-861.
49. Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, et al. (2005) Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis target genes. J Biol Chem 280: 27728-27741.
50. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, et al. (1999) Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 19: 6742-6753.
51. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, et al. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18: 4969-4980.
52. Makarova O, Kamberov E, Margolis B, (2000) Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29: 970-972.
53. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H, et al. (2005) MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 280: 9706-9718.
54. Rzeczkowski K, Beuerlein K, Muller H, Dittrich-Breiholz O, Schneider H, et al. (2011) c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. J Cell Biol 194: 581-596.